Flecainide for heart arrest

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Nov 2022: Trial registered, NCT05631730
  2. 4 Jan 2023: Trial started, NCT05631730

The trials

NCT05631730: Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse

State
Under way
Phase
Phase 3
People
50 planned
Started
4 Jan 2023
Primary completion
Aug 2028
Arms
Flecainide and Metoprolol
Results
None posted
  1. 30 Nov 2022: Trial registered
  2. 4 Jan 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.